GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Option Care Health Inc (NAS:OPCH) » Definitions » Research & Development
中文

Option Care Health (Option Care Health) Research & Development

: $0 Mil (TTM As of Dec. 2023)
View and export this data going back to 1996. Start your Free Trial

Research & Development is the aggregate amount of research and development expenses during the year. Option Care Health's Research & Development for the three months ended in Dec. 2023 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was $0 Mil.

Option Care Health Research & Development Historical Data

The historical data trend for Option Care Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Option Care Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Option Care Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Option Care Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Option Care Health  (NAS:OPCH) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Option Care Health Research & Development Related Terms

Thank you for viewing the detailed overview of Option Care Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Option Care Health (Option Care Health) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Option Care Health Inc (NAS:OPCH) » Definitions » Research & Development
Comparable Companies
ENSG ACHC SEM SGRY EHC AMED AGL AMN LFST CHE HCA SAU:4013 SZSE:300015 XTER:FRE BKK:BDMS UHS DVA ADX:PUREHEALTH BSP:RDOR3 XTER:FME
Traded in Other Exchanges
MM6A:Germany
Address
3000 Lakeside Drive, Suite 300N, Bannockburn, IL, USA, 60015
Website
https://www.optioncarehealth.com
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders among others.
Executives
Elizabeth D Bierbower director HUMANA INC., 500 W. MAIN ST., LOUISVILLE KY 40202
R Carter Pate director 5739 WORTHAM LANE, DALLAS TX 75252
Smyser Collin officer: Gen. Counsel & Corp. Secy. C/O OPTION CARE HEALTH, 3000 LAKESIDE DR. SUITE 300N, BANNOCKBURN IL 60015
Kraemer Harry M Jansen Jr director DENTSPLY SIRONA INC., 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Michael Bavaro officer: Chief Human Resources Officer 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN IL 60015
Luke Whitworth officer: Chief Operating Officer 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN IL 60015
Walgreens Boots Alliance, Inc. 10 percent owner 108 WILMOT ROAD, DEERFIELD IL 60015
Hc Group Holdings I, Llc 10 percent owner THREE FIRST NATIONAL PLAZA, SUITE 4600, CHICAGO IL 60602
Wba Investments, Inc. 10 percent owner 108 WILMOT ROAD, DEERFIELD IL 60015
Och Us Holding Llc 10 percent owner 200 WILMOT ROAD, DEERFIELD IL 60015
Wba Us 1 Co. 10 percent owner 180 WILMOT ROAD, DEERFIELD IL 60015
Harriet Booker officer: CHIEF OPERATING OFFICER C/O BIOSCRIP, INC., 1600 BROADWAY, SUITE 700, DENVER CO 80202
Natasha Deckmann director 7114 EAST STETSON DRIVE, SUITE 400, SCOTTSDALE AZ 85251
Anita M. Allemand director 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN IL 60015
Aaron Friedman director 3000 LAKESIDE DRIVE, SUITE 300N, BANNOCKBURN IL 60015